title: Gene expression profiling of lens tumors, liver and spleen in α-crystallin/SV40 T antigen transgenic mice treated with Juzen-taiho-to.
abstract: The autogenic lens tumors induced by the Simian vacuolating virus 40 (SV40) T antigen in α-crystallin/SV40 T antigen transgenic (TG) mice, provide a tool to screen anti-tumor reagents in vivo and to clarify the underlying mechanisms. Juzen-taiho-to, a Chinese medicine composed of 10 herbs, was frequently used as an alternative medicine for cancer patients by clinicians and occasionally it was demonstrated to have beneficial effects on the prognosis and general condition of cancer patients. However, it was not scientifically verified. In the present study, the anti-tumor effects and underlying mechanisms of Juzen-taiho-to in the TG mice model was examined using cDNA microarray analysis and the results were confirmed by real-time PCR. The TG mice demonstrated a higher cumulative survival rate after treatment with the drug compared with the control group (P<0.05). Gene chip profiles demonstrated that cell functions involving the membrane, glycoprotein, cell membrane, signal and ionic channel for the lens tumor, the cell cycle, DNA replication, homeobox, mitosis and cell division for the spleen and the acetylation, mitochondrion, ribosomal protein, ribonucleoprotein for the liver, were altered by the administration of Juzen‑taiho-to. The important canonical pathways were those of the mitogen-activated protein kinase (MAPK), the cell cycle and the ribosome for the altered genes of the lens tumor, spleen and liver after drug administration, respectively. From real-time PCR, in the eyeball, epidermal growth factor receptor (Egfr), Rasgrf1 and heat shock protein 1B (Hspa1b) mRNAs were found to be significantly lower in treated lenses than in those not exposed to the drug, while Rps25 mRNA demonstrated the opposite association in the liver. It was suggested that Juzen-taiho-to may prolong the survival time of SV40 T antigen TG mice by improving their nutritional condition, inhibiting the MAPK pathway and strengthening the immune system without causing hepatic toxicity.
authors: Cancer Research Center, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China.
authors: Hua-Chuan
authors: HC
authors: Zheng
authors: Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa 241‑0815, Japan.
authors: Akira
authors: A
authors: Noguchi
authors: Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa 241‑0815, Japan.
authors: Keiji
authors: K
authors: Kikuchi
authors: Ajinomoto Co., Inc., Chuo-ku, Tokyo 104‑8315, Japan.
authors: Toshihiko
authors: T
authors: Ando
authors: Department of Obstetrics and Gynecology, Kawasaki Medical School, Kurasiki, Okayama 701-0192, Japan.
authors: Takafumi
authors: T
authors: Nakamura
authors: Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa 241‑0815, Japan.
authors: Yasuo
authors: Y
authors: Takano
mesh_terms: D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005134:Eye Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology / Q000821:virology; D020869:Gene Expression Profiling; D007908:Lens, Crystalline; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D020411:Oligonucleotide Array Sequence Analysis; D013539:Simian virus 40 / Q000472:pathogenicity; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D038201:alpha-Crystallins / Q000235:genetics / Q000378:metabolism*
chemical_list: D000952:Antigens, Polyomavirus Transforming; D004365:Drugs, Chinese Herbal; D038201:alpha-Crystallins; C063587:juzentaihoto